Correspondence to letter to the editor on “Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study” - Young Eun Chon; Dong Yun Kim; Hong Jae Chon; Do Young Kim (Clinical and Molecular Hepatology)